Empirical Finance, LLC Vertex Pharmaceuticals Inc Transaction History

Empirical Finance, LLC

$1.7 Billion
Q3 2024

A detailed history of Empirical Finance, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Empirical Finance, LLC holds 8,916 shares of VRTX stock, worth $4.48 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

8,916

Previous 8,726 2.18%

Holding current value

$4.48 Million

Previous $4.09 Million 1.37%

% of portfolio

0.24%

Previous 0.26%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$460.0 - $505.78 $87,400 - $96,098	190 Added 2.18%	8,916 $4.15 Million
Q2 2024 Jul 30, 2024	SELL	$392.81 - $485.53 $238,042 - $294,231	-606 Reduced 6.49%	8,726 $4.09 Million
Q1 2024 May 06, 2024	BUY	$407.69 - $446.08 $147,583 - $161,480	362 Added 4.04%	9,332 $3.9 Million
Q3 2023 Nov 02, 2023	BUY	$338.18 - $362.46 $292,525 - $313,527	865 Added 10.67%	8,970 $3.12 Million
Q2 2023 Jul 27, 2023	BUY	$314.42 - $351.91 $294,925 - $330,091	938 Added 13.09%	8,105 $2.85 Million
Q1 2023 Apr 05, 2023	BUY	$283.23 - $323.1 $97,714 - $111,469	345 Added 5.06%	7,167 $2.26 Million
Q4 2022 Jan 24, 2023	BUY	$285.76 - $321.48 $155,739 - $175,206	545 Added 8.68%	6,822 $1.97 Million
Q3 2022 Nov 04, 2022	BUY	$273.83 - $305.53 $282,592 - $315,306	1,032 Added 19.68%	6,277 $1.82 Million
Q2 2022 Aug 01, 2022	BUY	$234.96 - $292.55 $64,144 - $79,866	273 Added 5.49%	5,245 $1.48 Million
Q1 2022 Apr 21, 2022	BUY	$221.42 - $260.97 $117,352 - $138,314	530 Added 11.93%	4,972 $1.3 Million
Q4 2021 Feb 04, 2022	BUY	$177.01 - $223.45 $208,694 - $263,447	1,179 Added 36.13%	4,442 $975,000
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $33,738 - $37,756	186 Added 6.04%	3,263 $592,000
Q2 2021 Aug 10, 2021	BUY	$187.49 - $221.1 $80,245 - $94,630	428 Added 16.16%	3,077 $620,000
Q4 2020 Feb 02, 2021	BUY	$207.01 - $276.09 $96,466 - $128,657	466 Added 21.35%	2,649 $626,000
Q3 2020 Oct 28, 2020	BUY	$255.65 - $303.1 $558,083 - $661,667	2,183 New	2,183 $594,000
Q3 2020 Oct 26, 2020	SELL	$255.65 - $303.1 $434,093 - $514,663	-1,698 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$225.48 - $295.8 $382,865 - $502,268	1,698 New	1,698 $493,000
Q2 2020 Jul 20, 2020	SELL	$225.48 - $295.8 $334,161 - $438,375	-1,482 Closed	0 $0
Q1 2020 Apr 16, 2020	BUY	$199.77 - $247.81 $106,477 - $132,082	533 Added 56.16%	1,482 $353,000
Q4 2019 Jan 27, 2020	BUY	$166.71 - $223.91 $158,207 - $212,490	949 New	949 $208,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.

Account

Empirical Finance, LLC Vertex Pharmaceuticals Inc Transaction History